Alzamend Neuro (ALZN) Net Equity Issued and Repurchased (2021 - 2026)
Alzamend Neuro's Net Equity Issued and Repurchased was $7.35 million in fiscal Q1 2027 (quarter ended Jul 31, 2026), up 82.2% from $4.04 million a year earlier.
Powered by 
Analysis
Alzamend Neuro (ALZN) Net Equity Issued and Repurchased (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, Alzamend Neuro's Net Equity Issued and Repurchased was $17.95 million through Jul 31, 2026, up 83.0% year-over-year; for FY2026 (ended Apr 30, 2026), it came in at $4.04 million, down 47.8% from FY2025.
- Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 14.0% (FY2021 to FY2026).
- In earlier fiscal years, Net Equity Issued and Repurchased was $7.74 million in FY2025 (+517.7%), $1.25 million in FY2024, $200.00 in FY2023 (-100.0%) and $12.91 million in FY2022 (+514.8%).
- The fiscal Q1 2027 figure marks the highest quarterly Net Equity Issued and Repurchased since fiscal Q1 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 43.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 9.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Alzamend Neuro | 6.61 Mn | 6.61 Mn | - | 7.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 7.35 Mn |
| Jul 31, 2025 | 4.04 Mn |
| Apr 30, 2025 | 5.87 Mn |
| Jan 31, 2025 | 688,700.00 |
| Oct 31, 2024 | -789,420.00 |
| Jul 31, 2024 | 1.96 Mn |
| Apr 30, 2024 | 269,888.00 |
| Jan 31, 2024 | 964,450.00 |
| Jul 31, 2021 | 12.91 Mn |
API Access
Alzamend Neuro Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ALZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "ALZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ALZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();